Timing of initiation of calcineurin inhibitors in pediatric haploidentical transplantation with post-transplantation cyclophosphamide: Effects on survival, relapse, and cytokine release syndrome
dc.authorid | Vedat Uygun / 0000-0003-3257-7798 | en_US |
dc.authorscopusid | Vedat Uygun / 10043117000 | |
dc.authorwosid | Vedat Uygun / AGH-4534-2022 | |
dc.contributor.author | Uygun, Vedat | |
dc.contributor.author | Karasu, Gülsüm | |
dc.contributor.author | Yalçın, Koray | |
dc.contributor.author | Öztürkmen, Seda | |
dc.contributor.author | Daloğlu, Hayriye | |
dc.contributor.author | Çelen, Safiye Suna | |
dc.contributor.author | Hazar, Volkan | |
dc.contributor.author | Yeşilipek, Akif | |
dc.date.accessioned | 2022-07-25T13:42:08Z | |
dc.date.available | 2022-07-25T13:42:08Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Hastane | en_US |
dc.description.abstract | Background: The use of unmanipulated haploidentical hematopoietic stem cell transplantations (haplo-HSCT) with post-transplant cyclophosphamide (PTCY) in children has emerged as an acceptable alternative to the patients without a matched donor. However, the timing of calcineurin inhibitors (CNIs) used in combination with PTCY is increasingly becoming a topic of controversy. Method: We evaluated 49 children with acute leukemia who underwent unmanipulated haplo-HSCT with PTCY according to the initiation day of CNIs (pre- or post-cyclophosphamide [CY]). Results: There were no significant differences in the overall survival analysis between the 2 groups. The cumulative incidence of relapse at 2 years was 21.2% in the pre-CY group and 38.9% in the post-CY group (p = 0.33). Cytokine release syndrome (CRS) was observed more frequently in the post-CY group (p = 0.04). The overall survival and event-free survival at 2 years in patients with and without CRS in the pre-CY group were 42.9% versus 87.5% (p = 0.04) and 38.1% versus 87.5% (p = 0.04), respectively. Conclusion: Our study shows that the argument for starting CNI administration after CY is tenuous, and the rationale for not starting CNIs before CY needs to be reconsidered. | en_US |
dc.identifier.citation | Uygun V, Karasu G, Yalçın K, Öztürkmen S, Daloğlu H, Çelen SS, Hazar V, Yeşilipek A. Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome. Acta Haematol. 2022;145(4):362-370. doi: 10.1159/000521211. Epub 2021 Nov 30. PMID: 34847551. | en_US |
dc.identifier.doi | 10.1159/000521211 | en_US |
dc.identifier.endpage | 370 | en_US |
dc.identifier.issn | 0001-5792 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 34847551 | en_US |
dc.identifier.scopus | 2-s2.0-85123510630 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 362 | en_US |
dc.identifier.uri | http://doi.org/10.1159/000521211 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/3044 | |
dc.identifier.volume | 145 | en_US |
dc.identifier.wos | WOS:000906458600003 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Uygun, Vedat | |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.relation.ispartof | Acta Haematologica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acute Leukemia | en_US |
dc.subject | Calcineurin Inhibitors | en_US |
dc.subject | Children | en_US |
dc.subject | Cyclophosphamide | en_US |
dc.subject | Cytokine Release Syndrome | en_US |
dc.subject | Haploidentical | en_US |
dc.title | Timing of initiation of calcineurin inhibitors in pediatric haploidentical transplantation with post-transplantation cyclophosphamide: Effects on survival, relapse, and cytokine release syndrome | en_US |
dc.type | Article | en_US |